Market Brief: Orthobiologics Market Will See Modest Growth By 2024, Stimulated By Growth Factors
Global sales of orthobiologics products are expected to reach $2.8bn by 2024, a CAGR of 3.2%, led by the rising aging population and musculoskeletal disease.
You may also be interested in...
Tyto Care will use the proceeds to expand its telehealth and remote monitoring solution to the US, Europe, and Asia, and add AI capabilities.
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
Truvian Sciences will use the proceeds to fund regulatory submission for its POC testing system in Europe and the US with hopes to bring to retailers, pharmacies, health systems in 2022.